SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-121700
Filing Date
2014-03-28
Accepted
2014-03-28 17:00:53
Documents
3
Period of Report
2014-03-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d702386d8k.htm 8-K 12405
2 EX-99.1 d702386dex991.htm EX-99.1 48448
3 GRAPHIC g702386img1.jpg GRAPHIC 11174
  Complete submission text file 0001193125-14-121700.txt   77540
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 14726589
SIC: 2834 Pharmaceutical Preparations